Humacyte, Inc.

Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC), sponsored by Alpha Healthcare Acquisition Holdings LLC under the leadership of Rajiv Shukla, is a blank-check company that completed its initial public offering in 2020 with a focus on the healthcare and life sciences sector. In February 2021, AHAC filed an 8-K disclosing material developments related to its pursuit of a business combination with Humacyte, Inc., a clinical-stage biotechnology company developing bioengineered human acellular vessels. The transaction ultimately closed in August 2021, with the combined company trading on Nasdaq under the ticker HUMA. Visit SpacDesk and sign up for full data on AHAC, Humacyte, and hundreds of other SPAC transactions across every stage and sector.